T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A94.4 KBTheseus Pharmaceuticals, Inc.Feb 16, 4:00 PM ET·0001214659-24-003018
- 8-K415.3 KBTheseus Pharmaceuticals, Inc.Feb 14, 10:44 AM ET·0001104659-24-023155
- SC 13G/A247.6 KBTheseus Pharmaceuticals, Inc.Feb 13, 12:36 PM ET·0001193125-24-033273
- SC 13D/A98.3 KBTheseus Pharmaceuticals, Inc.Jan 12, 6:02 AM ET·0001214659-24-000664
- 8-K539.2 KBTheseus Pharmaceuticals, Inc.Dec 4, 6:30 AM ET·0001104659-23-123002
- 8-K203.2 KBTheseus Pharmaceuticals, Inc.Nov 27, 6:37 AM ET·0001104659-23-121095
- SC 13D/A144.4 KBTheseus Pharmaceuticals, Inc.Nov 24, 4:28 PM ET·0000947871-23-001103
- SC 13D/A135.9 KBTheseus Pharmaceuticals, Inc.Nov 24, 4:23 PM ET·0000950142-23-002837
- SC 13D124.4 KBTheseus Pharmaceuticals, Inc.Nov 24, 1:49 PM ET·0001214659-23-015548
- 8-K157.4 KBTheseus Pharmaceuticals, Inc.Oct 31, 4:13 PM ET·0001745020-23-000057
Insiders
10- Dahms Bradford D.President and CFO
- Dukes Iain D.Director
- Foresite Capital Fund V, L.P.10% Owner
- Foresite Capital Management V, LLC10% Owner
- GORDON CARL LDirector, 10% Owner
- HAYDEN DONALD J JRDirector
- Omega Fund VI, L.P.Former 10% owner
- ORBIMED ADVISORS LLCDirector, 10% Owner
- Rock Springs Capital Management LP10% Owner
- Rock Springs Capital Master Fund LP10% Owner
Tickers
No tickers on record
Addresses
business
314 MAIN STREET, SUITE 04-200
CAMBRIDGE, MA, 02142
mailing
314 MAIN STREET, SUITE 04-200
CAMBRIDGE, MA, 02142